Vaccines:
Indications for SHINGRIX:
Prevention of herpes zoster (shingles) in adults ≥50yrs of age.
Limitations of Use:
Not for preventing primary varicella infection (chickenpox).
Adult:
<50yrs: not recommended. Give by IM inj in deltoid region of upper arm. ≥50yrs: one 0.5mL dose at Month 0 followed by second dose anytime between 2–6 months later. Administer immediately upon reconstitution or store refrigerated and use within 6hrs.
Children:
<18yrs: not established.
Contraindications:
Allergies to any previous Shingrix vaccination.
Warnings/Precautions:
Review immunization history prior to administration. Have appropriate medical treatment and supervision available to manage allergic reactions. Pregnancy. Nursing mothers.
Pharmacologic Class:
Shingles vaccine.
Interactions:
Immunosuppressants may reduce efficacy of Shingrix. Concomitant inactivated influenza vaccines: see full labeling.
Adverse Reactions:
Local reactions (eg, pain, redness, swelling), myalgia, fatigue, headache, shivering, fever, GI symptoms.
Note:
To report adverse events, contact VAERS at (800) 822-7967.
Generic Availability:
NO
How Supplied:
Single-dose vials—1, 10 (antigen + adjuvant components)
